Stock market announcement archive

LIFECARE ASA: Extraordinary General Meeting

September 3, 2024
Lifecare ASA, a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), will hold an Extraordinary General Meeting 17 September 2024, at 09:00 (CEST). For the planned uplisting from Euronext Growth Oslo to Oslo Børs, a share consolidation is required to meet the NOK 10 per share listing requirement. Additionally, to […]
Read more

Correction: LIFE: Lifecare ASA Q2 2024

August 30, 2024
Reference is made to the Q2 2024 report published by Lifecare ASA (the “Company”) on 27 August 2024. In connection with the uplisting to Euronext Oslo Børs, the Company has conducted new assessments of its financial statements and, in collaboration with its auditor, concluded to recognize the warrants issued in connection with the previously announced […]
Read more

LIFE: Lifecare ASA Q2 2024

August 27, 2024
Bergen, Norway, 27 August 2024: Today, Lifecare ASA (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes Q2 financial report and operational update. In the second quarter Lifecare continued to build positive momentum towards automatic production by delivering milestones on a continuous basis over a long […]
Read more

Lifecare ASA Q2 2024 presentation

August 22, 2024
Lifecare ASA will release its second quarter 2024 results on Tuesday 27 august 2024 at 07:00 a.m. CEST. The same day at 12:00 CEST, CEO Joacim Holter will present the results live at Carnegie AS, Fjordalleen 16, Aker Brygge in Oslo. After the presentation, Lifecare invites to 1:1 session with the CEO and the CFO. […]
Read more

LIFE – Successfully completed nine weeks of longevity trials

August 21, 2024
Bergen, Norway, 21 August 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), can announce positive results from nine weeks of sensor longevity trials. Reference is made to press releases 18 June 2024 when the company initiated the trials with wireless readout. The Sencell sensor […]
Read more

LIFE: Strategic cooperation to make glucose data more accessible

August 13, 2024
Bergen, Norway, August 13, 2024: Lifecare ASA, a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), is pleased to announce a strategic cooperation with OneTwo Analytics AB (OneTwo), a Swedish-based company specializing in data analytics of diabetes data. The strategic cooperation will provide Lifecare access to OneTwo’s portfolio of comprehensive […]
Read more

LIFE – Successfully completed four weeks of longevity trials

July 17, 2024
Bergen, Norway, 17 July 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), can announce positive results from the first four week of sensor longevity trials. Reference is made to press releases 18 June 2024 when the company initiated the trials with wireless readout. The […]
Read more

LIFE: Cleanroom arrived in Hamburg

July 2, 2024
Bergen, Norway, July 2, 2024: Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that the cleanroom for automated production has arrived in Hamburg. Reference is made to Lifecare’s stock exchange announcement March 5, 2024, regarding placing a purchase order for cleanroom in connection with the […]
Read more

LIFE: Successfully completed first week of longevity trials

June 27, 2024
Bergen, Norway, 27 June 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), can announce positive results from the first week of sensor longevity trials. Reference is made to press release 18 June 2024 when the company initiated the trials with wireless readout. Already after […]
Read more